Gelfos-M scoops domestic antacid market

Published: 2004-03-29 07:00:00

Updated: 2004-03-29 07:00:00

Boryung Pharm's Gelfos-M, Korea's renowned antacid brand for the past 30 years, has regained its popularity with higher sales revenue thanks to official brand recognition and customers' higher awareness. Its sales record at the end of the first quarter is estimated at 6.0 billion won, a 25-percen...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK